| HSD17B1 |
|---|
 |
| Identifiers |
|---|
| Aliases | HSD17B1, EDH17B2, EDHB17, HSD17, SDR28C1, hydroxysteroid (17-beta) dehydrogenase 1, hydroxysteroid 17-beta dehydrogenase 1, E2DH, 17-beta-HSD, 20-alpha-HSD, Hsd17b1 |
|---|
| External IDs | OMIM: 109684; MGI: 105077; GeneCards: HSD17B1 |
|---|
| Available structures |
|---|
| PDB | Ortholog search: PDBe RCSB |
|---|
| List of PDB id codes |
|---|
1A27, 1BHS, 1DHT, 1EQU, 1FDS, 1FDT, 1FDU, 1FDV, 1FDW, 1I5R, 1IOL, 1JTV, 1QYV, 1QYW, 1QYX, 3DEY, 3DHE, 3HB4, 3HB5, 3KLM, 3KLP, 3KM0 |
|
|
|
|
|
|
|
|
| Wikidata |
|
17β-Hydroxysteroid dehydrogenase 1 (17β-HSD1) is an enzyme that in humans is encoded by the HSD17B1 gene.[5][6][7] This enzyme oxidizes or reduces the C17 hydroxy/keto group of androgens and estrogens and hence is able to regulate the potency of these sex steroids
Discovery
Human 17β-HSD1 was the first enzyme of the 17β-HSD family to be cloned and to have its sequence identified.[9][10] Its three-dimensional structure is also the first example of any human steroid-converting enzyme.[11]
Structure
This enzyme contains a short-chain dehydrogenase domain that contains a characteristic 3-layer (αβα) sandwich known as a Rossmann fold. The human enzyme contains 327 amino acids and exists as a homodimer with two identical subunits of 34.5 kDa [10][12] The N-terminal short-chain dehydrogenase domain contains binding site for the NADP+/NADPH cofactor. A narrow, hydrophobic C-terminal domain contains a binding pocket for the steroid substrate.
Clinical significance
Estradiol stimulates while dihydrotestosterone (DHT) inhibits breast cancer growth. Furthermore 17β-HSD1 levels positively correlate with estradiol and negatively correlate with DHT levels in breast cancer cells. Hence 17β-HSD1 represents a possible drug target for breast cancer treatment.[13]
References
- 1 2 3 GRCh38: Ensembl release 89: ENSG00000108786 – Ensembl, May 2017
- 1 2 3 GRCm38: Ensembl release 89: ENSMUSG00000019301 – Ensembl, May 2017
- ↑ "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
- ↑ "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
- ↑ Luu-The V, Labrie C, Simard J, Lachance Y, Zhao HF, Couët J, Leblanc G, Labrie F (Feb 1990). "Structure of two in tandem human 17 beta-hydroxysteroid dehydrogenase genes". Molecular Endocrinology. 4 (2): 268–75. doi:10.1210/mend-4-2-268. PMID 2330005.
- ↑
- ↑ "Entrez Gene: HSD17B1 Hydroxysteroid (17-beta) dehydrogenase 1".
- ↑ Saloniemi T, Jokela H, Strauss L, Pakarinen P, Poutanen M (2012). "The diversity of sex steroid action: novel functions of hydroxysteroid (17β) dehydrogenases as revealed by genetically modified mouse models". The Journal of Endocrinology. 212 (1): 27–40. doi:10.1530/JOE-11-0315. PMID 22045753.
- ↑ Luu The V, Labrie C, Zhao HF, Couët J, Lachance Y, Simard J, Leblanc G, Côté J, Bérubé D, Gagné R (Aug 1989). "Characterization of cDNAs for human estradiol 17 beta-dehydrogenase and assignment of the gene to chromosome 17: evidence of two mRNA species with distinct 5'-termini in human placenta". Molecular Endocrinology. 3 (8): 1301–9. doi:10.1210/mend-3-8-1301. PMID 2779584.
- 1 2 Peltoketo H, Isomaa V, Mäentausta O, Vihko R (Oct 1988). "Complete amino acid sequence of human placental 17 beta-hydroxysteroid dehydrogenase deduced from cDNA". FEBS Letters. 239 (1): 73–7. doi:10.1016/0014-5793(88)80548-9. PMID 2846351. S2CID 32468574.
- ↑ Ghosh D, Pletnev VZ, Zhu DW, Wawrzak Z, Duax WL, Pangborn W, Labrie F, Lin SX (May 1995). "Structure of human estrogenic 17 beta-hydroxysteroid dehydrogenase at 2.20 A resolution". Structure. 3 (5): 503–13. doi:10.1016/S0969-2126(01)00183-6. PMID 7663947.
- ↑ Lin SX, Yang F, Jin JZ, Breton R, Zhu DW, Luu-The V, Labrie F (Aug 1992). "Subunit identity of the dimeric 17 beta-hydroxysteroid dehydrogenase from human placenta". The Journal of Biological Chemistry. 267 (23): 16182–7. doi:10.1016/S0021-9258(18)41984-9. PMID 1322895.
- ↑ Aka JA, Mazumdar M, Chen CQ, Poirier D, Lin SX (Apr 2010). "17beta-hydroxysteroid dehydrogenase type 1 stimulates breast cancer by dihydrotestosterone inactivation in addition to estradiol production". Molecular Endocrinology. 24 (4): 832–45. doi:10.1210/me.2009-0468. PMC 5417535. PMID 20172961.
- ↑ "International Nonproprietary Names for Pharmaceutical Substances (INN) Proposed INN List 130" (PDF). Retrieved 15 August 2024.
Further reading
- Blomquist CH (Dec 1995). "Kinetic analysis of enzymic activities: prediction of multiple forms of 17 beta-hydroxysteroid dehydrogenase". The Journal of Steroid Biochemistry and Molecular Biology. 55 (5–6): 515–24. doi:10.1016/0960-0760(95)00200-6. PMID 8547176. S2CID 21487072.
- Lin SX, Shi R, Qiu W, Azzi A, Zhu DW, Dabbagh HA, Zhou M (Mar 2006). "Structural basis of the multispecificity demonstrated by 17beta-hydroxysteroid dehydrogenase types 1 and 5". Molecular and Cellular Endocrinology. 248 (1–2): 38–46. doi:10.1016/j.mce.2005.11.035. PMID 16480815. S2CID 19087697.
- Peltoketo H, Isomaa V, Vihko R (Oct 1992). "Genomic organization and DNA sequences of human 17 beta-hydroxysteroid dehydrogenase genes and flanking regions. Localization of multiple Alu sequences and putative cis-acting elements". European Journal of Biochemistry. 209 (1): 459–66. doi:10.1111/j.1432-1033.1992.tb17310.x. PMID 1327779.
- Winqvist R, Peltoketo H, Isomaa V, Grzeschik KH, Mannermaa A, Vihko R (Oct 1990). "The gene for 17 beta-hydroxysteroid dehydrogenase maps to human chromosome 17, bands q12-q21, and shows an RFLP with ScaI". Human Genetics. 85 (5): 473–6. doi:10.1007/BF00194219. PMID 1977681. S2CID 38282181.
- Luu-The V, Labrie C, Zhao HF, Couët J, Lachance Y, Simard J, Côté J, Leblanc G, Lagacé L, Bérubé D (1990). "Purification, cloning, complementary DNA structure, and predicted amino acid sequence of human estradiol 17 beta-dehydrogenase". Annals of the New York Academy of Sciences. 595: 40–52. doi:10.1111/j.1749-6632.1990.tb34281.x. PMID 2197970. S2CID 37554424.
- Baker ME (May 1989). "Human placental 17 beta-hydroxysteroid dehydrogenase is homologous to NodG protein of Rhizobium meliloti". Molecular Endocrinology. 3 (5): 881–4. doi:10.1210/mend-3-5-881. PMID 2547159.
- Tremblay Y, Ringler GE, Morel Y, Mohandas TK, Labrie F, Strauss JF, Miller WL (Dec 1989). "Regulation of the gene for estrogenic 17-ketosteroid reductase lying on chromosome 17cen----q25". The Journal of Biological Chemistry. 264 (34): 20458–62. doi:10.1016/S0021-9258(19)47083-X. PMID 2584224.
- Luu The V, Labrie C, Zhao HF, Couët J, Lachance Y, Simard J, Leblanc G, Côté J, Bérubé D, Gagné R (Aug 1989). "Characterization of cDNAs for human estradiol 17 beta-dehydrogenase and assignment of the gene to chromosome 17: evidence of two mRNA species with distinct 5'-termini in human placenta". Molecular Endocrinology. 3 (8): 1301–9. doi:10.1210/mend-3-8-1301. PMID 2779584.
- Peltoketo H, Isomaa V, Mäentausta O, Vihko R (Oct 1988). "Complete amino acid sequence of human placental 17 beta-hydroxysteroid dehydrogenase deduced from cDNA". FEBS Letters. 239 (1): 73–7. doi:10.1016/0014-5793(88)80548-9. PMID 2846351. S2CID 32468574.
- Nicolas JC, Harris JI (Jan 1973). "Human placental 17 -oestradiol dehydrogenase. Sequence of a tryptic peptide containing an essential cysteine". FEBS Letters. 29 (2): 173–6. doi:10.1016/0014-5793(73)80554-X. PMID 4719204. S2CID 44967040.
- Burns DJ, Engel LL, Bethune JL (Jul 1972). "Amino acid composition and subunit structure. Human placental 17 -estradiol dehydrogenase". Biochemistry. 11 (14): 2699–703. doi:10.1021/bi00764a023. PMID 5045524.
- Murdock GL, Chin CC, Offord RE, Bradshaw RA, Warren JC (Oct 1983). "Human placental estradiol 17 beta-dehydrogenase. Identification of a single histidine residue affinity-labeled by both 3-bromoacetoxyestrone and 12 beta-bromoacetoxy-4-estrene-3,17-dione". The Journal of Biological Chemistry. 258 (19): 11460–4. doi:10.1016/S0021-9258(17)44248-7. PMID 6578212.
- Andersson S, Geissler WM, Patel S, Wu L (Jun 1995). "The molecular biology of androgenic 17 beta-hydroxysteroid dehydrogenases". The Journal of Steroid Biochemistry and Molecular Biology. 53 (1–6): 37–9. doi:10.1016/0960-0760(95)00039-3. PMID 7626483. S2CID 54417090.
- Tremblay MR, Auger S, Poirier D (May 1995). "Synthesis of 16-(bromoalkyl)-estradiols having inhibitory effect on human placental estradiol 17 beta-hydroxysteroid dehydrogenase (17 beta-HSD type 1)". Bioorganic & Medicinal Chemistry. 3 (5): 505–23. doi:10.1016/0968-0896(95)00041-E. PMID 7648200.
- Ghosh D, Pletnev VZ, Zhu DW, Wawrzak Z, Duax WL, Pangborn W, Labrie F, Lin SX (May 1995). "Structure of human estrogenic 17 beta-hydroxysteroid dehydrogenase at 2.20 A resolution". Structure. 3 (5): 503–13. doi:10.1016/S0969-2126(01)00183-6. PMID 7663947.
- Sawetawan C, Milewich L, Word RA, Carr BR, Rainey WE (Mar 1994). "Compartmentalization of type I 17 beta-hydroxysteroid oxidoreductase in the human ovary". Molecular and Cellular Endocrinology. 99 (2): 161–8. doi:10.1016/0303-7207(94)90004-3. PMID 8206323. S2CID 54331976.
- Normand T, Narod S, Labrie F, Simard J (Apr 1993). "Detection of polymorphisms in the estradiol 17 beta-hydroxysteroid dehydrogenase II gene at the EDH17B2 locus on 17q11-q21". Human Molecular Genetics. 2 (4): 479–83. doi:10.1093/hmg/2.4.479. PMID 8389226.
- Zhao Z, Yazdani A, Shen Y, Sun Z, Bailey J, Caskey CT, Lee CC (Sep 1996). "Molecular dissection of a cosmid from a gene-rich region in 17q21 and characterization of a candidate gene for alpha-N-acetylglucosaminidase with two cDNA isoforms". Mammalian Genome. 7 (9): 686–90. doi:10.1007/s003359900206. PMID 8703123. S2CID 8692823.
PDB gallery |
|---|
1a27: HUMAN 17-BETA-HYDROXYSTEROID-DEHYDROGENASE TYPE 1 C-TERMINAL DELETION MUTANT COMPLEXED WITH ESTRADIOL AND NADP+
1bhs: HUMAN ESTROGENIC 17BETA-HYDROXYSTEROID DEHYDROGENASE
1dht: ESTROGENIC 17-BETA HYDROXYSTEROID DEHYDROGENASE COMPLEXED DIHYDROTESTOSTERONE
1equ: TYPE 1 17-BETA HYDROXYSTEROID DEHYDROGENASE EQUILIN COMPLEXED WITH NADP+
1fds: HUMAN 17-BETA-HYDROXYSTEROID-DEHYDROGENASE TYPE 1 COMPLEXED WITH 17-BETA-ESTRADIOL
1fdt: HUMAN 17-BETA-HYDROXYSTEROID-DEHYDROGENASE TYPE 1 COMPLEXED WITH ESTRADIOL AND NADP+
1fdu: HUMAN 17-BETA-HYDROXYSTEROID-DEHYDROGENASE TYPE 1 MUTANT H221L COMPLEXED WITH ESTRADIOL AND NADP+
1fdv: HUMAN 17-BETA-HYDROXYSTEROID-DEHYDROGENASE TYPE 1 MUTANT H221L COMPLEXED WITH NAD+
1fdw: HUMAN 17-BETA-HYDROXYSTEROID-DEHYDROGENASE TYPE 1 MUTANT H221Q COMPLEXED WITH ESTRADIOL
1i5r: TYPE 1 17-BETA HYDROXYSTEROID DEHYDROGENASE EM1745 COMPLEX
1iol: ESTROGENIC 17-BETA HYDROXYSTEROID DEHYDROGENASE COMPLEXED 17-BETA-ESTRADIOL
1jtv: Crystal structure of 17beta-Hydroxysteroid Dehydrogenase Type 1 complexed with Testosterone
1qyv: Crystal structure of human estrogenic 17beta-hydroxysteroid dehydrogenase complex with NADP
1qyw: Crystal structure of human estrogenic 17beta-hydroxysteroid dehydrogenase comlex with androstanedione and NADP
1qyx: Crystal structure of human estrogenic 17beta-hydroxysteroid dehydrogenase complex with androstenedione and NADP
3dhe: ESTROGENIC 17-BETA HYDROXYSTEROID DEHYDROGENASE COMPLEXED DEHYDROEPIANDROSTERONE
|